Sign in Request access
Sign inRequest access
OpenTender 31 Dec 2028, 23:58 (UTC+01:00)

Open House Biologika Rabattverträge 2026-33 Pertuzumab / Trastuzumab (Wirkstoffkombination)

At a glance

Techniker Krankenkasse is procuring Pharmaceutical products (CPV 33600000) in Hamburg (DE600). The notice gives 31 December 2028, 23:58 (UTC+01:00) as the deadline. Procedure type: Open.

From the notice

Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge nach § 130c Abs. 1 SGB V zu der Wirkstoffkombination Pertuzumab / Trastuzumab zu schließen. Der Vertragsschluss erfolgt im Rahmen des Open-House-Verfahrens der TK: Individuelle Verhandlungen über Vertragsinhalte werden nicht geführt, es gelten einheitliche Konditionen. Die TK sichert einzelnen Vertragspartnern keine Exklusivität zu. Die Vertragslaufzeit beträgt maximal 24 Monate beginnend mit dem 01.01.2027. Der Vertrag endet spätestens am 31.12.2028, unabhängig vom Datum des Vertragsschlusses. Bei Patentablauf/Ablauf der Marktexklusivität vor dem o.g. Enddatum endet der Vertrag automatisch mit Ablauf des Monats des Patentablaufs/der Marktexklusivität. Alle weiteren Informationen sind den Teilnahme- und Vertragsunterlagen zu entnehmen.

Key facts

Each fact is from the official notice, last checked 7 November 2026, 07:11 (UTC+01:00).

Status
OpenOfficial notice · checked 7 Nov 2026, 07:11 (UTC+01:00)
Deadline
(in 784 days)Official notice · checked 7 Nov 2026, 07:11 (UTC+01:00)
Buyer
Techniker Krankenkasse, Hamburg, DEOfficial notice · checked 7 Nov 2026, 07:11 (UTC+01:00)
Place of performance
Hamburg (DE600)Official notice · checked 7 Nov 2026, 07:11 (UTC+01:00)
Main CPV
Pharmaceutical products (CPV 33600000)Official notice · checked 7 Nov 2026, 07:11 (UTC+01:00)
Procedure
OpenOfficial notice · checked 7 Nov 2026, 07:11 (UTC+01:00)
Lots
1Official notice · checked 7 Nov 2026, 07:11 (UTC+01:00)
First published
4 November 2026, 17:16 (UTC+01:00)Official notice · checked 7 Nov 2026, 07:11 (UTC+01:00)

Fact sheet

Inteliwert fact sheet: Open House Biologika Rabattverträge 2026-33 Pertuzumab / Trastuzumab (Wirkstoffkombination) — Techniker Krankenkasse, deadline 31 December 2028, 23:58 (UTC+01:00). A product of Bandpey GmbH.
The key facts of this page as an image (PNG, 1600 × 900), made from the official notice. © Bandpey GmbH; terms of use. Download the fact sheet

Lots (1)

  1. Lot LOT-0001: Open House Biologika Rabattverträge 2026-33 Pertuzumab / Trastuzumab (Wirkstoffkombination)

    Die TK verfolgt das Ziel, mit allen geeigneten pharmazeutischen Unternehmern Rabattverträge § 130c Abs. 1 SGB V zu der Wirkstoffkombination Pertuzumab / Trastuzumab zu schließen.

    CPV
    Pharmaceutical products (CPV 33600000)
    Place
    Hamburg (DE600)
    Deadline

Timeline

  1. 4 November 2026, 17:16 (UTC+01:00): Original notice Notice, version 01 (Contract or concession notice – standard regime). Official notice

Buyer and place

Buyer

Techniker Krankenkasse
Hamburg, DE

Place of performance

  • Hamburg (DE600)

Classification

CPV codes

  • 33600000: Pharmaceutical products

NUTS regions

  • DE600: Hamburg

Official documents

Links go to the publisher. Inteliwert does not copy the documents.

Questions and answers

When is the deadline?

The official notice gives 31 December 2028, 23:58 (UTC+01:00) as the deadline.

Who is the buyer?

Techniker Krankenkasse, Hamburg, DE.

What is being procured (CPV)?

Pharmaceutical products (CPV 33600000).

Where is the work performed (NUTS)?

Hamburg (DE600).

Is it divided into lots?

No, the notice names a single lot.

Which procedure is used?

Open.

How do I submit a bid?

On the official notice or the portal it names. Inteliwert does not submit bids. Official notice

Am I eligible?

Inteliwert does not judge eligibility. The selection criteria are in the official notice. Official notice

Companies that might fit

Possible match based on public information

Companies Inteliwert knows from its sources, not the whole market. Inteliwert does not judge eligibility, fit or chances.

  • Besins Healthcare Germany GmbH

    Berlin
    SME (from the award notice)
    • Won a contract in CPV group 336 (2026-11-04) Evidence · checked 7 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 7 Nov 2026

  • Medicopharm AG

    Nußdorf am Inn
    SME (from the award notice)
    • Won a contract in CPV group 336 (2024-09-01) Evidence · checked 7 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 7 Nov 2026

  • Allomedic GmbH

    Köln
    SME (from the award notice)
    • Won a contract in CPV group 336 (2024-09-01) Evidence · checked 7 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 7 Nov 2026

  • ACA Müller ADAG Pharma AG

    Gottmadingen
    SME (from the award notice)
    • Won a contract in CPV group 336 (2024-10-01) Evidence · checked 7 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 7 Nov 2026

  • APONTIS PHARMA Deutschland GmbH & Co. KG

    Monheim am Rhein
    SME (from the award notice)New to public tenders
    • Won a contract in CPV group 336 (2026-09-29) Evidence · checked 7 Nov 2026
    • Seat in the same country as the place of performance Evidence · checked 7 Nov 2026

More from this buyer

Other published opportunities of this buyer in the indexed notices, open ones first.

Source

Publisher
TED
Last checked
7 November 2026, 07:11 (UTC+01:00)

The official notice is authoritative. Inteliwert shows what the notice states and links to it.

Markdown version